Resultados de la búsqueda 131-140 of 10210 for Liver haemangioma

  1. Enfermedad hepática del hígado graso no alcohólico - Médicos y departamentos - Mayo Clinic

    Centro Bariátrico en Florida · Centro Pediátrico de Mayo Clinic · Clínica para Trastornos Hepatobiliares · Endocrinología · Gastroenterología y Hepatología · Liver ...

  2. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    1. Create a registry of patients having or at risk for cancer of the liver or bile ducts (also known as hepatocellular carcinoma or cholangiocarcinoma), or ...

  3. Radiología - Ensayos clínicos - Mayo Clinic

    Patients may receive a single dose to a liver lobe or segmental treatment delivered as a sequence of treatments approximately 30-90 days apart. The principal ...

  4. Hematología - Ensayos clínicos - Mayo Clinic

    All study subjects will receive acalabrutinib, durvalumab, and venetoclax. Acalabrutinib is FDA approved for treatment of chronic lymphocytic leukemia and small ...

  5. Radiología - Ensayos clínicos - Mayo Clinic

    Patients may receive a single dose to a liver lobe or segmental treatment delivered as a sequence of treatments approximately 30-90 days apart. The principal ...

  6. Cirugía - Ensayos clínicos - Mayo Clinic

    Levels of bladder cancer-derived extracellular vesicles become undetectable after radical cystectomy in patients with localized bladder cancer. This study hopes ...

  7. Hematología - Ensayos clínicos - Mayo Clinic

    Ascorbic acid may make cancer cells more sensitive to chemotherapy. Drugs used in chemotherapy, work in different ways to stop the growth of cancer cells, ...

  8. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    1. Create a registry of patients having or at risk for cancer of the liver or bile ducts (also known as hepatocellular carcinoma or cholangiocarcinoma), or ...

  9. Hematología - Ensayos clínicos - Mayo Clinic

    All study subjects will receive acalabrutinib, durvalumab, and venetoclax. Acalabrutinib is FDA approved for treatment of chronic lymphocytic leukemia and small ...

  10. Hematología - Ensayos clínicos - Mayo Clinic

    The purpose of this study is to determine adverse events and change in disease symptoms of ABBV-383 in adult participants with relapsed/refractory (R/R) MM.